indiamart semaglutide Alkem Launches India's First Single-Shot Pre-Filled Syringe at INR 350 to Boost Affordable Diabetes and Obesity Care. Head to our website to read more: https://indiamedtoday.com/alkem-laboratories-has-launched- semaglutide-in-single-shot-pre OZEMPIC 1MG (SEMAGLUTIDE) Supplier, OZEMPIC

Before Branded 10,85016,400 per month (Novo Nordisk Wegovy) Source: Business Today After Indian Generics 1,2904,500 per month (50+ brands) Source: Bloomberg Prices are indicative as of March 2026

On 21 May 2026 , Lilly published the long-awaited topline results from the TRIUMPH-1 Phase 3 trial, and the data is striking: participants on the highest dose lost an average of 28.3% of their body weight at 80 weeks , with 45.3% of patients losing 30% or more a threshold previously only achievable with bariatric surgery

The participants were given GLP-1 medications like semaglutidethe active ingredient in Ozempic and Wegovy and naltrexone (Vivitrol), which are designed to manage obesity and type 2 diabetes by interacting with the hunger part of the brain to suppress the appetite, and lowering blood sugar and A1C

For athletes and body-recomp goals, the signal is promising , but evidence-based protocols require human trials to confirm efficacy, safety, and optimal integration with training/nutrition